223 related articles for article (PubMed ID: 20013257)
1. Pharmacokinetics of linezolid in septic patients with and without extended dialysis.
Swoboda S; Ober MC; Lichtenstern C; Saleh S; Schwenger V; Sonntag HG; Haefeli WE; Hempel G; Hoppe-Tichy T; Weigand MA
Eur J Clin Pharmacol; 2010 Mar; 66(3):291-8. PubMed ID: 20013257
[TBL] [Abstract][Full Text] [Related]
2. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure.
Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Sagripanti S; Manini P; Andreoli R; Cabassi A
Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148
[TBL] [Abstract][Full Text] [Related]
3. Does haemodialysis significantly affect serum linezolid concentrations in critically ill patients with renal failure? A pilot investigation.
Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Manini P; Andreoli R; Cabassi A
Nephrol Dial Transplant; 2006 May; 21(5):1402-6. PubMed ID: 16504979
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intravenous and oral linezolid in adults with cystic fibrosis.
Keel RA; Schaeftlein A; Kloft C; Pope JS; Knauft RF; Muhlebach M; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2011 Jul; 55(7):3393-8. PubMed ID: 21518837
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of linezolid in patients treated in a compassionate-use program.
Meagher AK; Forrest A; Rayner CR; Birmingham MC; Schentag JJ
Antimicrob Agents Chemother; 2003 Feb; 47(2):548-53. PubMed ID: 12543657
[TBL] [Abstract][Full Text] [Related]
6. Does linezolid inhibit its own metabolism? Population pharmacokinetics as a tool to explain the observed nonlinearity in both healthy volunteers and septic patients.
Plock N; Buerger C; Joukhadar C; Kljucar S; Kloft C
Drug Metab Dispos; 2007 Oct; 35(10):1816-23. PubMed ID: 17639029
[TBL] [Abstract][Full Text] [Related]
7. Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration.
Meyer B; Kornek GV; Nikfardjam M; Karth GD; Heinz G; Locker GJ; Jaeger W; Thalhammer F
J Antimicrob Chemother; 2005 Jul; 56(1):172-9. PubMed ID: 15905303
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure.
Tsuji Y; Hiraki Y; Mizoguchi A; Hayashi W; Kamohara R; Kamimura H; Karube Y
J Infect Chemother; 2008 Apr; 14(2):156-60. PubMed ID: 18622681
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetic evaluation of linezolid in patients with major thermal injuries].
Le Floch R; Arnould JF; Vinsonneau C; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Lovering AM
Pathol Biol (Paris); 2010 Apr; 58(2):e27-31. PubMed ID: 19854590
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.
Buerger C; Plock N; Dehghanyar P; Joukhadar C; Kloft C
Antimicrob Agents Chemother; 2006 Jul; 50(7):2455-63. PubMed ID: 16801426
[TBL] [Abstract][Full Text] [Related]
11. Single-dose linezolid pharmacokinetics in critically ill patients with impaired renal function especially chronic hemodialysis patients.
El-Assal MI; Helmy SA
Biopharm Drug Dispos; 2014 Oct; 35(7):405-16. PubMed ID: 25044219
[TBL] [Abstract][Full Text] [Related]
12. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
[TBL] [Abstract][Full Text] [Related]
13. Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.
Luque S; Grau S; Alvarez-Lerma F; Ferrández O; Campillo N; Horcajada JP; Basas M; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Nov; 44(5):409-15. PubMed ID: 25216547
[TBL] [Abstract][Full Text] [Related]
14. Single dose pharmacokinetics of linezolid in infants and children.
Kearns GL; Abdel-Rahman SM; Blumer JL; Reed MD; James LP; Jacobs RF; Bradley JA; Welshman IR; Jungbluth GL; Stalker DJ;
Pediatr Infect Dis J; 2000 Dec; 19(12):1178-84. PubMed ID: 11144380
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of ampicillin/sulbactam in critically ill patients with acute kidney injury undergoing extended dialysis.
Lorenzen JM; Broll M; Kaever V; Burhenne H; Hafer C; Clajus C; Knitsch W; Burkhardt O; Kielstein JT
Clin J Am Soc Nephrol; 2012 Mar; 7(3):385-90. PubMed ID: 22223613
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.
Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH
J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic evaluation of linezolid in patients with major thermal injuries.
Lovering AM; Le Floch R; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Vinsonneau C
J Antimicrob Chemother; 2009 Mar; 63(3):553-9. PubMed ID: 19153078
[TBL] [Abstract][Full Text] [Related]
18. Linezolid pharmacokinetics in adult patients with cystic fibrosis.
Bosso JA; Flume PA; Gray SL
Antimicrob Agents Chemother; 2004 Jan; 48(1):281-4. PubMed ID: 14693551
[TBL] [Abstract][Full Text] [Related]
19. Continuous administration of linezolid in pneumonia: what is the level of proof?
Mimoz O; Montravers P; Paiva JA
Intensive Care Med; 2015 Jan; 41(1):157-9. PubMed ID: 25425443
[No Abstract] [Full Text] [Related]
20. Linezolid pharmacokinetics in patients with acute renal failure undergoing continuous venovenous hemodiafiltration.
Carcelero E; Soy D; Guerrero L; Poch E; Fernandez J; Castro P; Ribas J
J Clin Pharmacol; 2012 Sep; 52(9):1430-5. PubMed ID: 21960670
[No Abstract] [Full Text] [Related]
[Next] [New Search]
